Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Halfon

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
Viruses|July 27, 2022
Cell and Animal Models for SARS-CoV-2 ResearchEloïne Bestion, Philippe Halfon, Soraya Mezouar, et al.
Journal of Clinical Microbiology|July 11, 2006
Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infectionPhilippe Halfon, Marc Bourlière, Guillaume Pénaranda, et al.
Comparative Hepatology|December 24, 2005
Kinetics of hepatitis C virus RNA load during pegylated interferon alpha-2a and ribavirin treatment in naïve genotype 1 patientsDenis Ouzan, Hacène Khiri, Guillaume Pénaranda, et al.
European Journal of Gastroenterology & Hepatology|March 31, 2015
Nationwide large survey on hepatitis B surface antigen quantification use in real-life clinical practicePhilippe Halfon, Guillaume Penaranda, Sofiane Mohamed, et al.
Clinical Medicine Insights. Case Reports|July 20, 2011
Incident HPV 51 Infection After Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/SilgardPhilippe Halfon, Sophie Ravet, Hacène Khiri, et al.
Cancer Cytopathology|July 25, 2013
Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus typesFreija Verdoodt, Anne Szarewski, Philippe Halfon, et al.
Annales De Biologie Clinique|April 17, 2014
[Cytological and virological medium performance and stability assessment using the Cobas 4800 HPV test (Roche Diagnostics) used in France]Hacène Khiri, Claire Camus, Mireille Portugal, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 5, 2013
Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogsDenis Ouzan, Guillaume Pénaranda, Hélène Joly, et al.
Journal of Clinical Microbiology|May 31, 2002
Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serumPascale Trimoulet, Philippe Halfon, Eric Pohier, et al.
HIV Clinical Trials|January 31, 2002
Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlationsAlain Lafeuillade, Caroline Solas, Philippe Halfon, et al.
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
Viruses|July 27, 2022
Cell and Animal Models for SARS-CoV-2 ResearchEloïne Bestion, Philippe Halfon, Soraya Mezouar, et al.
Journal of Clinical Microbiology|July 11, 2006
Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infectionPhilippe Halfon, Marc Bourlière, Guillaume Pénaranda, et al.
Comparative Hepatology|December 24, 2005
Kinetics of hepatitis C virus RNA load during pegylated interferon alpha-2a and ribavirin treatment in naïve genotype 1 patientsDenis Ouzan, Hacène Khiri, Guillaume Pénaranda, et al.
European Journal of Gastroenterology & Hepatology|March 31, 2015
Nationwide large survey on hepatitis B surface antigen quantification use in real-life clinical practicePhilippe Halfon, Guillaume Penaranda, Sofiane Mohamed, et al.
Clinical Medicine Insights. Case Reports|July 20, 2011
Incident HPV 51 Infection After Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/SilgardPhilippe Halfon, Sophie Ravet, Hacène Khiri, et al.
Cancer Cytopathology|July 25, 2013
Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus typesFreija Verdoodt, Anne Szarewski, Philippe Halfon, et al.
Annales De Biologie Clinique|April 17, 2014
[Cytological and virological medium performance and stability assessment using the Cobas 4800 HPV test (Roche Diagnostics) used in France]Hacène Khiri, Claire Camus, Mireille Portugal, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 5, 2013
Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogsDenis Ouzan, Guillaume Pénaranda, Hélène Joly, et al.
Journal of Clinical Microbiology|May 31, 2002
Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serumPascale Trimoulet, Philippe Halfon, Eric Pohier, et al.
HIV Clinical Trials|January 31, 2002
Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlationsAlain Lafeuillade, Caroline Solas, Philippe Halfon, et al.
Pageof 16